Home › Funds › MAK CAPITAL ONE LLC › LAB

MAK CAPITAL ONE LLC position in LAB

STANDARD BIOTOOLS INC · Industrials

MAK CAPITAL ONE LLC reported holding 28,813,904 shares of LAB (STANDARD BIOTOOLS INC) in its Q2 2026 13F filing — a position valued at US$23.7M, representing 3.32% of its reported portfolio and ranking #11 among its reported holdings. MAK CAPITAL ONE LLC has disclosed LAB holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)28.81M sh
Reported value held$23.71M
Portfolio Weight3.32%
First reportedQ1 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How MAK CAPITAL ONE LLC's LAB position evolved

MAK CAPITAL ONE LLC first disclosed a stake in LAB in Q1 2025 at 2,774,721 shares (US$3.0M). The position peaked in Q4 2025 at 19,288,158 shares, worth US$24.7M. Across 6 filings, MAK CAPITAL ONE LLC increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 28,813,904 shares valued at US$23.7M — an increase of 2,641,278 shares quarter over quarter.. Notable position changes include a 102% increase in Q2 2025 (shares rose 8% over the following quarter), a 185% increase in Q3 2025 (shares fell 2% over the following quarter), a 36% increase in Q1 2026 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 2.77M $3.00M New
Q2 2025 5.60M $6.72M Add
Q3 2025 15.93M $20.71M Add
Q4 2025 19.29M $24.69M Add
Q1 2026 26.17M $24.06M Add
Q2 2026 28.81M $23.71M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LAB and 13F data

LAB (STANDARD BIOTOOLS INC) is a Industrials company. 21 other funds we track also report a position in LAB — the largest reported positions include Casdin Capital (US$73.0M), Long Focus Capital Management, LLC (US$19.3M), Hollow Brook Wealth Management LLC (US$4.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LAB

All LAB fund holders →

FAQ

How long has MAK CAPITAL ONE LLC held LAB?

MAK CAPITAL ONE LLC has disclosed LAB holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is MAK CAPITAL ONE LLC's current position in LAB?

As of Q2 2026, MAK CAPITAL ONE LLC holds 28.81M shares of LAB (STANDARD BIOTOOLS INC), valued at $23.71M, representing 3.32% of its reported portfolio and ranking #11.

Has MAK CAPITAL ONE LLC been buying or selling LAB?

In the latest 13F filing (Q2 2026), MAK CAPITAL ONE LLC increased its position in LAB. The position peaked in Q4 2025 at 19.29M shares.

Which other funds hold LAB?

Other major institutional holders of LAB include Casdin Capital, Long Focus Capital Management, LLC, Hollow Brook Wealth Management LLC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.